China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study of SHR-1701 Combined with Apatinib as Second-Line Therapy for Advanced Hepatocellular Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136329
Registration Time: 2026/11/10
Type: Interventional study
Primary Sponsor: Langfang Campus of Chinese Academy of Medical Sciences Cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342088
Published by HT Digital Content Services with permission from Health Daily Digest....